Risk factors for heart disease other than lipid elevations among people with HIV need close attention, according to an analysis of 394 patients at the Royal Free Hospital, London.
Cholesterol and triglyceride elevations after starting anti-HIV therapy have led some epidemiologists and clinicians to warn that an increasing incidence of heart disease may become apparent in a few year’s time among people with HIV.
Epidemiologists and doctors at the Royal Free Hospital reviewed risk factors among patients at the clinic. Forty-five per cent of the Royal Free cohort were smokers and 7% had an alcohol intake above the weekly recommended limit. 72% of current smokers had previously tried to stop.
- 20% had a BMI >26kg/m2 (associated with a higher risk of cardiovascular disease)
- 34% were aged over 40
- 29% reported a family history of heart disease
- 14% had hypertension
- 18% had total cholesterol > 6.3mmol/l
- 36% had non-fasting triglycerides > 2.3mmol/l
- 10% had HDL cholesterol
Among patients on HAART (73% of the cohort), raised cholesterol and triglyceride levels were significantly more common, as was a family history of heart disease (38% vs 30%, p=0.03).
However, patients on HAART were significantly less likely to smoke (43% vs 47%, p=0.03); it appeared that those who were ex-smokers (24% of the cohort) were more likely to have given up after starting HAART (65% of ex-smokers). The Royal Free Hospital offers smoking cessation courses for HIV-positive patients as part of its HIV clinic service.
Smith C et al. Cardiovascular disease risk factors and antiretroviral therapy in an HIV-positive UK population. Sixth International Congress on Drug Therapy in HIV Infection, Glasgow, abstract P162, 2002.